The GOFARR lab is developing novel tools for targeted treatments to preserve kidney function.
New genes implicated in disease create new therapeutic targets and ability to assess disease severity.
The Carl F. Braun Trust awards Children’s Hospital Los Angeles $1.92 million to conduct research on integrative techniques to alleviate pain in children.
A new study finds that patients’ mental health and quality of life change as they grow to adulthood.
Standard Test for Diagnosing Autism is Unnecessary when Developmental Behavioral Pediatricians’ Certainty is High, Study Suggests
Developmental behavioral pediatricians’ professional judgment does not require the “gold standard” test for autism in the vast majority of cases.
Combining Erythropoietin with Therapeutic Hypothermia Does Not Improve Outcomes of Infants with Neonatal HIE, Study Finds
Children’s Hospital Los Angeles imaging researchers developed biomarkers for a study seeking treatments for infants with oxygen deprivation damage By Wendy Wolfson According to the results of a study conducted on 500 infants, adding erythropoietin (Epo) to...
Tiredness and fatigue. Frequent headaches. Brain fog. These are just a few symptoms of long COVID that can persist weeks after a COVID-19 infection. Find out how researchers at Children’s Hospital Los Angeles are studying new ways to manage and potentially treat long COVID.
Since arriving at CHLA in March 2021, Hillary has been busy getting the new Alfred E. Mann Family Foundation Zebrafish Facility up and running.